Chemical compound produces beneficial inflammation, remyelination that could help treat MS
Credit: I. Pittalwala. UC Riverside. RIVERSIDE, Calif. -- Drugs available to treat multiple sclerosis, a leading cause of neurological disability affecting roughly 2.3 million people...







